Bank of America’s Biora Therapeutics, Inc. Common Stock BIOR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-159
| Closed | -$798 | – | 8611 |
|
|
2024
Q3 | $798 | Buy |
159
+141
| +783% | +$915 | ﹤0.01% | 7293 |
|
|
2024
Q2 | $118 | Buy |
+18
| New | +$122 | ﹤0.01% | 7672 |
|
|
2024
Q1 | – | Sell |
-1
| Closed | -$18 | – | 8420 |
|
|
2023
Q4 | $18 | Buy |
+1
| New | +$16 | ﹤0.01% | 7678 |
|
|
2023
Q3 | – | Sell |
-124
| Closed | -$4.77K | – | 8171 |
|
|
2023
Q2 | $4.77K | Buy |
+124
| New | +$4.37K | ﹤0.01% | 7004 |
|
|
2023
Q1 | – | Sell |
-1
| Closed | -$48 | – | 8680 |
|
|
2022
Q4 | $48 | Sell |
1
-1
| -50% | -$73 | ﹤0.01% | 7808 |
|
|
2022
Q3 | $0 | Buy |
+2
| New | +$360 | ﹤0.01% | 8444 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 9036 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 8895 |
|
|
2021
Q3 | – | Sell |
-18
| Closed | -$16K | – | 8558 |
|
|
2021
Q2 | $16K | Sell |
18
-130
| -88% | -$99.4K | ﹤0.01% | 7206 |
|
|
2021
Q1 | $176K | Buy |
148
+134
| +957% | +$185K | ﹤0.01% | 6115 |
|
|
2020
Q4 | $18K | Sell |
14
-9
| -39% | -$13.2K | ﹤0.01% | 6617 |
|
|
2020
Q3 | $52K | Buy |
+23
| New | +$52K | ﹤0.01% | 6000 |
|
Bank of America's BIOR Position: Q4 2024 in Review
Bank of America sold out of Biora Therapeutics, Inc. Common Stock (BIOR) in Q4 2024, closing a stake of 159 shares — an estimated $798 sold.
Bank of America first reported a position in BIOR in Q3 2020 and held it in 10 quarters. The position peaked at $176K in Q1 2021. 0 funds tracked by Wall St. Rank hold BIOR as of Q4 2024.
- Bank of America reported no remaining Biora Therapeutics, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
- Bank of America sold 159 Biora Therapeutics, Inc. Common Stock shares in Q4 2024, an estimated $798.
- Bank of America first reported a position in Biora Therapeutics, Inc. Common Stock in Q3 2020 and held it in 10 quarters.
- Bank of America's Biora Therapeutics, Inc. Common Stock position peaked at $176K in Q1 2021.
- 0 funds tracked by Wall St. Rank held Biora Therapeutics, Inc. Common Stock as of Q4 2024.
Based on Bank of America's 13F filing for Q4 2024, filed 14 Feb 2025.